Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
domenica, ottobre 11
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Co-Diagnostics Inc
CODX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$1.12
0.03
2.75%
Ult. Agg.: Oct 9, 4:00 PM
$1.09
N/A
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Privacy Manager
Co-Diagnostics Financials
Co-Diagnostics (CODX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Stock Market Today: S&P 500, Dow Futures Fall as Oil Tops $99 Despite Trump’s Price Drop Prediction — ASML, NVS, CASY in Focus
Stock Market Today: S&P 500, Dow Futures Fall as Oil Tops $99 Despite Trump’s Price Drop Prediction— ASML, NVS, CASY in Focus
Rishabh Mishra
United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday
Stocks in focus: UNFI and ABM earnings, Novartis trial miss, Co-Diagnostics CFO change, and Casey’s earnings expected.
Avi Kapoor
PRO
Co-Diagnostics Q2 EPS $(1.46) Beats $(3.00) Estimate, Sales $166.131K Miss $166.500K Estimate
Co-Diagnostics (OTC:CODX) reported quarterly losses of $(1.46) per share which beat the analyst consensus estimate of $(3.00) by 51.33 percent. This is a 78.84 percent increase over losses of $(6.90) per share from the
Benzinga Newsdesk
PRO
Co-Diagnostics Q1 EPS $(4.06) Misses $(3.90) Estimate, Sales $145.954K Miss $163.500K Estimate
Benzinga Newsdesk
Earnings Scheduled For May 14, 2026
Benzinga Insights
PRO
Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY
Co-Diagnostics (OTC:CODX) reported quarterly losses of $(16.65) per share. This is a 53.88 percent decrease over losses of $(10.82) per share from the same period last year. The company reported $263.922 thousand in
Benzinga Newsdesk
